[Federal Register Volume 60, Number 151 (Monday, August 7, 1995)]
[Notices]
[Pages 40186-40187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-19413]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Recombinant DNA Advisory Committee; Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee on September 11-12, 1995. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 6, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on September 11, 1995, at approximately 9 
a.m., and will recess at approximately 6 p.m. The meeting will 
reconvene on September 12, 1995, at approximately 8:30 a.m. and will 
adjourn at approximately 5 p.m. The meeting will be open to the public 
to discuss Proposed Actions under the NIH Guidelines for Research 
Involving Recombinant DNA Molecules (59 FR 34496) and other matters to 
be considered by the Committee. The Proposed Actions to be discussed 
will follow this notice of meeting. Attendance by the public will be 
limited to space available. Members of the public wishing to speak at 
this meeting may be given such opportunity at the discretion of the 
Chair.
    Dr. Nelson A. Wivel, Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at 
this meeting, roster of committee members, and substantive program 
information. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should contact Dr. Wivel in advance of the meeting. A 
summary of the meeting will be available at a later date.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
not only virtually every NIH program but also essentially every Federal 
research program in which DNA recombinant molecule techniques could be 
used, it has been determined not to be cost effective or in the public 
interest to attempt to list these programs. Such a list would likely 
require several additional pages. In addition, NIH could not be certain 
that every Federal program would be included as many 

[[Page 40187]]
Federal agencies, as well as private organizations, both national and 
international, have elected to follow the NIH Guidelines. In lieu of 
the individual program listing, NIH invites readers to direct questions 
to the information address above about whether individual programs 
listed in the Catalog of Federal Domestic Assistance are affected.

    Dated: August 2, 1995.
Susan K. Feldman,
Committee Management Officer, National Institute of Health.
[FR Doc. 95-19413 Filed 8-4-95; 8:45 am]
BILLING CODE 4140-01-M